Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe somebody could explain why as of January 23 2019, Lanxess Corp is the correspondent for the following two patents Bioamber International S.a.r.l. assigned over to Bioamber Inc;
https://assignment.uspto.gov/patent/index.html#/patent/search/resultAssignment?id=48112-672
https://legacy-assignments.uspto.gov/assignments/assignment-pat-48112-672.pdf
Per otce.finra.org , clearly states Bioamber's "CUSIP suspended", not cancelled.
For example of a cancellation; Per otce.finra.org , clearly states Amyris' "bankruptcy plan effective/ shares cancelled"
On another note;
It's a shame PTT withdrew their bid due to PWC leaking/publishing their info online prior to the confidential bid deadline, PTTMCC Biochem wouldn't have to import bio-succinic acid for their bio-pbs.
Greenfield wanted the shares, PTT offered between $40-$60 million for certain assets, & PWC released both of these bidder's info prior to the confidential bidder's deadline.
Intangible assets defined by Mitsui (Bioamber's secured creditor)
Goodwill and Other Intangible Assets:
"Other intangible assets include primarily customer relationships, trademarks, non-compete agreements, sales/supply agreements, patents, unpatented technologies, software, and in-place lease values."...."Identifiable intangible assets with a finite useful life are amortized on a straight line basis over their estimated useful lives (ranging from 1 to 40 years) and reviewed for impairment in accordance with ASC 360"..."Any identifiable intangible assets determined to have indefinite useful lives are not amortized, but instead tested for impairment in accordance with ASC 360 until the useful life is determined to be no longer indefinite." -referenced a Mitsui-USA annual report
Mitsui's definition of "intangible assets" coupled with their agreement in August 2017 with Bioamber (that clearly stated if Bioamber declared bankruptcy, Mitsui would have control of the Bioamber's Sarnia plant & operations) not only contradicts PWC reports & statements regrading tangible & intangible assets, it makes me wonder why it took 4 years & millions of dollars in bio-succinic acid delivered to Mitsui for Mitsui to sign patents over to LCY. Perhaps an agreement outside of the CCAA/liquidation process?
Side Question: Didn't PTT's bid include purchase of shares? I do remember PWC leaking confidential bidder's info which included PTT's bid info.
I doubt you have "an issue" with liars or lying, considering you & your cohorts dismiss events pointing to PWC, Visolis, LCY, Mitsui, & Bioamber colluding.
Corporate collusion, price-fixing, false and/or omitted statements, especially in the biotech space, seems to be rampant and has negativly effected thousands if not millions of people, Yet your here taking joy trying to spin-kick every shareholder's opinion & DD.
Thanks for the reminder. All intriguing including PTT owning 97% of Myriant inlcuding their Louisiana bio-succinic acid plant, yet PTT sells the Lousiana succinic acid plant for an undisclosed amount, rename & restructured Myriant into PTT GC Innovation America, and forms a JV with Mitsui in August 2018 (Bioamber's largest secured creditor). All the while both Mitsui & PTTMCC continued to buy bio-succinic acid from LCY Biosciences?
https://bioplasticsnews.com/2018/08/21/myriant-becomes-gc-innovation-america-ptt-natureworks/#
All above are just facts including PTT the ticker you mentioned.
If I were to really contemplate a conspiracy theory, I'd probably question the true cause of the confidential bidders leak resulting in PTT rescinding their bid and 2 weeks later Mitsui & PTT announcing their JV.
I find it interesting Mistubishi (MUFG) lends a billion-plus to LCY for their ESG efforts, while MCC in PTTMCC (Mitsubishi Chemical Corp) is/was one of Bioamber's unsecured creditors.
One of Bioamber's customers/partners PTTMCC requires BIO-SA & BIO-BDO to manufacture their BIO-PBS in Thailand.
PTTMCC is still producing and exporting BIO-PBS to their customers as recent as January 08, 2024. (one of PTTMCC's consistent customers include the public-traded co; Danimer Scientific)
PTTMCC confirmed in one of their recent reports, they buy BIO-SA used in BIO-PBS through "short and long-term contracts" and does not manufacture BIO-SA at the moment.
PTTMCC claims a $1.9 billion market value for their BIO-PBS.
Anybody else thinking LCY Biosciences/Bioamber is receiving a licenses fee and/or renting out the Sarnia succinic plant to PTTMCC for the production of BIO-SA?
Maybe 'The San Francisco Business Times' would be interested in some of the events that occured in & around Bioamber's CCAA proceedings (i.e; confidential bidding leaks, late/lack of document postings on the monitor's website, ex-monitor employee meeting with Bioamber's C-Suite execs at conferences 6-7 months prior to winning bids, etc)
https://www.bizjournals.com/sanfrancisco/news/2023/11/16/amyris-bankruptcy-john-doerr-synbio.html
Great! Maybe you can explain the reasoning behind forming a Holding Company? (i.e a Biotechnology Holding Company, such as LCY Biotechnology Holding Company)
Suspended not cancelled. The few that feel compelled to dispute the difference please don't make the false claim of "indefinite suspension" unless a document using that term in reference to bioamber or cusip is shared on this board.
On another note, If this was over in October 2018, or even in November-December 2019;
Why did PWC claim to liquidate patents Mitsui had rights to?
why did Mitsui transfer those patents to LCY years later in Jan 2023 not in back in 2018-2022?
Why did PWC claim to liquidate yeast patents Cargill had co-development rights to?
Summer of 2019 PWC declared Greenfield's & PTTMCC's bids were significantly more than $4.34 million, and yet PWC failed to document they caused Greenfield & PTTMCC to withdraw their bids by leaking their bid info.
My point, some of PWC's actions didn't add up & shareholders noticed.
I consider Bioamber shares/CUSIP 09072Q106 an asset & probably useful when going for a leveraged ESG loan/SSL. IMO this adds an interesting dynamic as to why Bioamber shares are only suspended.
Some interesting points from the articles linked below on ESG leveraged loans/SSL (Sustainability Linked Loans) include; low interest rates & 5-6 year term lengths.
https://www.esginvestor.net/voting-collateral-in-focus-for-esg-securities-lending-framework/
https://www.vermeg.com/blog/how-can-esg-drive-new-choices-of-collateral/
https://www.eurex.com/ex-en/find/news/The-role-of-ESG-ratings-for-collateral-3452352
https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/insights/the-road-ahead-integrating-esg-standards-in-securities-lending-for-asset-owners.pdf
https://www.shoosmiths.com/insights/articles/the-basics-what-is-esg-lending
https://www.unpri.org/download?ac=5887
Didn't LCY adopt the ESG creed after PWC announced LCY's investment in Bioamber?
Is the ESG status considered a tangible or intangible asset?
How much would ESG status be worth?
Bioamber a environmental-friendly company with tangible assets such as a production plant & patents for producing bio-based chemicals such as BIO-SA & BIO-BDO. Sounds like ESG (imo).
After reading the August 08, 2023 article below about one of MUFG's (Mitsubishi UFJ Financial Group) key ESG deals (KKR/LCY, $1.2 billion) I do wonder what was leveraged in that $1.2 billion transaction.
"With a comprehensive global network, the bank’s strong suit is advisory and execution. MUFG has seen a significant increase in the volume of ESG deals in Taiwan, closing 12 such transactions in 2022 amounting to $2 billion. It served as sustainability coordinator or sole lender for 11 out of the 12 deals closed in Taiwan in the period, showcasing its segment expertise.
Key deals included:
- KKR-owned LCY Chemical Corp’s $1.2 billion multi-tranche syndicated SLL, in which MUFG participated as a MLA.The deal marked MUFG’s first leveraged finance transaction with KKR in Asia, and the largest sponsor-leveraged finance transaction completed in Taiwan."
https://www.financeasia.com/article/financeasia-awards-2022-2023-winner-write-ups-north-asia/485696
So instead, PTT decides to spend 4.84 million USD on 2,422,800 KGS of bio-succinic acid from LCY ? assuming @ $2.00/kg.
Still thinking about the bio-succinic acid plant PTTMCC is operating per the article linked in my previous post.
"To the best of our knowledge, only Roquette, BASF, and PTT-MCC Biochem continue to operate their bio-succinic acid production facilities"
Enhancing Succinic Acid Production by Sequential Adaptation of Selected Basfia succiniciproducens Strains to Arundo donax Hydrolysate
Received: 12 May 2023 / Revised: 13 June 2023 / Accepted: 14 June 2023 / Published: 16 June 2023
https://www.mdpi.com/2311-5637/9/6/573
Questions I have after reading this 2023 article/study while understanding bio succinic acid is key for PTTMCC's BIOPBS;
PTTMCC operating a succinic acid production facility? Where, Rayong, Thailand? Same location 2011-2014 articles quoting Bioamber's plans on building a facility?
Did LCY Biosciences license Bioamber's SA Production technology to PTTMCC ?
Per importgenius & other import/export sites alike record PTT purchasing succinic acid from LCY biosciences?
It still is interesting (to me) PWC leaked PTT confidential bid info for Bioamber prior to the bid submission to deadline.
Please share the link of the unredacted version of Bioamber-Solvay's partnership filing. Until then, maybe you can answer how LCY Biotechnology Holding Inc is claiming a loan value of $USD 1,065,028,980 (NTD,000 : 35,500,966,000) as of August 31, 2023?
A few articles out there state LCY Biotechnology Holding Inc was formed to purchase Bioamber's tangible assets.
LCY Biotechnology Holding Inc
https://www.lcyt.com.tw/tc/news-info.php?cid=3&nid=374&Page=0
i find it interesting when reading the redacted Bioamber-Solvay partenrship filing, and now knowing within 20 feet of each other on the same block (S Commerce Drive), LCY Electronic Materials Inc & Solvay are both setting up shop in Casa Grande, Arizona to produce elctronic cleaning/solvents (Solvay's Hydrogen Peroxide is produced to an electronics grade purification and used to supply the semi-conductor industry & LCY producing electronic grade lsopropyl Alcohol) Solvay's construction ending in Q4 2023, LCY's construction ending Q1 2024.
Source for Q4 2023 & Q1 2024 dates ;
https://destinyhosted.com/agenda_publish.cfm?id=22724&mt=ALL&vl=true
LCY Q1 2024 -
https://destinyhosted.com/agenda_publish.cfm?dsp=agm&seq=5321&rev=0&id=22724&form_type=AG_MEMO&beg_meetmth=9&beg_meetyr=2022&end_meetmth=9&end_meetyr=2023&mt=ALL&sstr=LCY&dept=ALL&hartkeywords=&sortby=f.form_num,%20f.rev_num&fp=ADVSRCH&StartRow=1
Solvay Q4 2023 -
https://destinyhosted.com/agenda_publish.cfm?dsp=agm&seq=5929&rev=0&id=22724&form_type=AG_MEMO&beg_meetmth=9&beg_meetyr=2022&end_meetmth=9&end_meetyr=2023&mt=ALL&sstr=SOLVAY&dept=ALL&hartkeywords=&sortby=f.form_num,%20f.rev_num&fp=ADVSRCH&StartRow=1
KKR said that the Lee family would have to come up with another US$290 million to buy the stake in Carlton [(Luxembourg) Holdings SARL] via an issuance of 200 million new shares.
KKR said that the Carlton [(Luxembourg) Holdings SARL] shares acquired following the takeover would not pay dividends and would have no liquidity in the next five years.
https://www.taipeitimes.com/News/biz/archives/2018/09/08/2003699991
Question: How and what did LCY do to come up with another US$290 million to buy their stake in Carlton, per this September 08, 2018 article?
My answer/opinion: After October 22, 2018, Bioamber's tangible assets were used as collateral for the additional US$290 million / 200 million shares that will not pay dividends until after 5 years.
KKR/LCY's deal closed 01/31/2019, then there was the day in Feb 2019 volume of BIOAQ shares traded BIOAQ spiked.
In addition, it has been mentioned LCY would be become public again outside of Taiwan somewhere between or after 5-7 years.
I am glad you mentioned CCAA, being that my original post regarding Mitsui releasing a patent to LCY Biosciences 6-7 months ago only after importing $13-$17 million of bio-succinic acid from LCY Biosciences indicates an arrangement was made between the two parties.
I don't need for you to explain anything but your point has been received = "Paid" means "Not Paid", Confidential bidder's info leaked has no relevance, Terms and Conditions means nothing, "Active means Inactive", "Suspended" means "Canceled" & so on.
"All amounts "OWING" that are SUBJECT to the KERP Charge have now been paid." - PWC
"Have now been paid" means not paid, Thanks trader59
As previously posted by another shareholder
"This has nothing to do with the KERP being used or not being used; let's make that clear off the bat." ............. "After the KERP Charge are unsecured creditors. So using the ranking of charges you can come up with "The KERP Line". The 8th Report says "All amounts "owing" that are SUBJECT to the KERP Charge have now been paid." So no matter how you want to define "subject to"; either everything above the KERP line has been paid or everything below the KERP line has been paid. WHY?"
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146526705
I checked the replies to this shareholders question & can't seem to find your response their question. Or am I to assume you believe the "KERP charge have now been paid" line was just another mistake similar to how bidders' info leaked prior to the bid deadline.
Reminder: Mistui (Bioamber secured creditor) owed $4,416,203 CAD - PWC
Reminder: 'All amounts owing to the KERP charge have been paid' - PWC
Why would Mitsui import/spend/buy (6,922,080 KGs / $13,844,160 - $17,305,200) of bio-succinic acid @ $2.00-$2.50/kg, last shipment being 8-9 months ago from LCY biosciences, when Mitsui was owed money? Good business decision, Bad business or Maybe an arrangement was made? Example; succinic acid to pay off debt..... CCAA = Companies' Creditors Arrangement Act
https://www.importgenius.com/suppliers/lcy-biosciences-inc
A month later Mitsui released/assigned the following patent over to LCY Biosciences; 'Processes For Producing Succinic Acid From Fermentation Broths Containing Diammonium Succinate'
https://assignment.uspto.gov/patent/index.html#/patent/search/resultAssignment?id=63754-959
1-2 days after the patent assignment from Mitsui, LCY biosciences switching from bio-succinic acid to carotenoids articles are published.
Feb 1, 2024 - 5 years KKR/LCY acquisition deal closed
Interesting considering Bioamber's debt/ creditor's list total per PWC totalled USD $48,682,498. ($63,224,024 CAD).
iF Mitsui's security agreement w/ Bioamber was null & void upon the vesting order and/or closing of the CCAA;
Why would LCY wait to request 2 seperate patent assignments (1st in April 2022, 2nd on January 25, 2023) from Mitsui?
IMO, it seems there was a (confidential) agreement between LCY & MITSUI which included achieving certain milestones such as Mitsui receiving $13-17 million USD worth of bio-succinic acid before certain patent assignments were conveyed.
As an example & considering upon signing the security agreement, Bioamber assigned those same patents and trademarks to Mitsui all within the same month of August 2017.
And to my original point, 1 day after the January 25, 2023 LCY patent assignment for Bioamber's bio-succinic production process, or 1-month after Mitsui received their last shipment of bio-succinic acid, Articles are published quoting LCY Biosciences' production shifting focus over to carotenoids.
2 different links for the January 25, 2023 Mitsui-LCY Biosciences patent assigment referenced in my previous post
https://legacy-assignments.uspto.gov/assignments/assignment-pat-62493-57.pdf
https://www.plainsite.org/patents/assignment.html?id=11250006
January 25, 2023; Bioamber's secured creditor, Mitsui, assigned the following (Bioamber's bio-succinic acid production process) patent over to LCY Biosciences after a request from LCY's patent attorney Robic.
https://legacy-assignments.uspto.gov/assignments/assignment-pat-6243-57.pdf
January 26-27, 2023; Articles are published about LCY Biosciences' focus on carotenoids production and quotes regarding succinic acid's global demand.
April-May 2023; Visolis' Rechemtex imports succinic acid from Qingdao Great Chemical Inc
https://www.importgenius.com/importers/rechemtex-llc-c-o-visolis-inc
"To show [my] work" or in other words why I believe Bioamber's NOLS have value, refer to the link below for my post in the LCY board referring to an article quoting LCY's executives discussing about Taiwain-US double taxation
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171996167
Moving goal-posts? Excuse buckets?
I've referenced Bioamber's Case 18-11078-LSS Doc 22 Filed 06/08/18, Pages 10-12, specifically section 2.3, State of Delaware being owed $49,548. If not paid already from the $1.9 million in Bioamber's checking account as noted on page 2, It seems $49,548 isn't whole lot for LCY to reactivate Bioamber Inc.
https://storage.courtlistener.com/recap/gov.uscourts.deb.173082/gov.uscourts.deb.173082.22.0.pdf
I've also posted about waiting for the 5 year anniversary of LCY stating their desire to become a publicly traded company again after 5 years.
- July 2023, 5 years since KKR announced their intention of acquiring LCY
- Jan - Feb 2024, 5 years since KKR finalized their acquisition of LCY
- Q1 2024, Completion of when LCY Electronic Materials' plant construction in Arizona.
After reading the following April 2023 article qouting LCY about double taxation between both Taiwan & the US, I can't but help think about the value of a certain company's NOLS, which shares are only suspended, not cancelled.
https://www.msn.com/en-us/money/other/double-tax-hinders-taiwan-s-investment-in-american-factories/ar-AA1aqp8L
Article linked above is copied out below;
"WASHINGTON—Bowei Lee’s chemical company wants to open a new American factory to make materials for semiconductors, exactly the type of investment U.S. officials are courting as they seek to shore up chip supply chains and boost domestic manufacturing.
But the Taiwan-based firm, LCY Group, faces a problem: Earnings from the new factory would be taxed twice.
A “double tax” conundrum involving Taiwanese businesses operating on American soil is straining business ties between the U.S. and Taiwan, a technology manufacturing powerhouse and central player in Washington’s plan to counter the rise of China and strengthen U.S. supply chains.
“It’s a big impediment to Taiwanese investments,” said Mr. Lee, chairman of LCY, which supplies materials to Taiwan Semiconductor Manufacturing Co., the huge chip maker that is building its own new facility in Phoenix. “Countries such as Canada and Germany have signed a double taxation treaty with Taiwan, but the U.S. has been very slow at that.”
Despite maintaining robust bilateral relations with Taiwan, the U.S. doesn’t have a formal diplomatic relationship with the island, which China considers part of its sovereign territory. In contrast to arrangements the U.S. has with all its other top trading partners—including China, South Korea, Japan and the European Union—Washington lacks a formal tax treaty with Taiwan.
Since a treaty is typically signed between countries with diplomatic ties, the spokesman for China’s Embassy in Washington, Liu Pengyu, said Beijing has urged the U.S. to cease “all forms of official interaction with Taiwan.”
The lack of a U.S. tax treaty with Taiwan means that Taiwanese businesses and individuals in the U.S. are taxed on their income by both governments and face higher rates for some other taxes.
Taiwan and its political allies are pressing the Biden administration to address the double tax problem.
“The lack of a tax treaty between Taiwan and the U.S. is making it very difficult for Taiwanese businesses to expand and operate in the U.S.,” Bi-khim Hsiao, Taiwan’s de facto ambassador to the U.S., said in a statement.
A new tax treaty would require congressional approval. Last month, a bipartisan group of six U.S. senators introduced a resolution calling on the Biden administration to start negotiating one.
But the Biden administration has yet to commit to address the tax issue.
In response to a question at a House hearing last month, Treasury Secretary Janet Yellen said her department and the State Department will look into the double taxation issue. “I do recognize that this is a very significant problem that we really need to explore ways to deal with,” she said.
While Taiwan has long-pressed the U.S. for a tax treaty, the issue has gained urgency due to an expected surge in Taiwanese investments in the U.S. propelled by the Chips Act. That 2022 law created generous incentives to ensure the U.S. has a domestic semiconductor industry that can compete with China’s and reduce reliance on imports from geopolitically vulnerable places such as Taiwan and South Korea.
Attracting investments from TSMC and its suppliers from Taiwan is particularly important, given that the U.S. relies on TSMC for more than 90% of its needs for the most sophisticated semiconductors. “That’s a vulnerability that’s unsustainable,” Commerce Secretary Gina Raimondo said in February.
To enhance economic ties with Taiwan, the two sides are also negotiating a new trade agreement. A record number of Taiwanese companies attended the U.S. government’s annual investment fair last year.
A spokeswoman for TSMC declined to comment on how the tax issue may affect its investment decision for the Phoenix facility, which is counting on generous financial support from the U.S. government as part of the Chips Act.
She said TSMC doesn’t take a position on double taxation. The company told the Commerce Department in a comment letter last year that the lack of a tax treaty has made it difficult for some of its Taiwanese suppliers to build new U.S. factories.
LCY, the TSMC supplier, currently has a production site in Texas. Mr. Lee said the new facility would pay federal, state and possibly municipal taxes and face a 30% withholding tax on its after-tax earnings if the money is remitted back home. In Taiwan, it would also pay a corporate tax and an individual dividend tax, he said.
Some Taiwanese companies have jumped through hoops to minimize their tax burdens.
For Advantech Co., a Taiwanese maker of industrial computers used for factory automation, U.S. sales now make up roughly 30% of revenue. To avoid double taxation, the company has opted to invest those earnings in the U.S. or Latin America, rather than sending profits home.
“This really distorts our corporate finance management,” said Chaney Ho, Advantech’s co-founder and a board director.
The high withholding tax, which reduces the amount of funds available for dividends, has also discouraged Advantech from increasing dividend payouts to shareholders, some 40% of whom are now American and other foreign investors. “It’s rather ridiculous that we make more money in the U.S., but we can’t pay dividends to the investors,” Mr. Ho said."
2015 Bio World Congress on Industrial Biotechnology attendees; Bioamber, Verdezyne, Visolis
https://www.bio.org/sites/default/files/legacy/bioorg/docs/2015_WC_Printed_Program.pdf
Thanks for sharing this form which also shows bioamber's assets outweighing the liabilities
Why the 3.5 year delay for the following patent to be released (on April 07 2022) by the secured party Mitsui over to LCY Biosciences Inc?
https://www.plainsite.org/patents/assignment.html?id=11066555
I am not sure what arrangements were made between LCY & Mitsui for such a delay with this patent assignment but during that same 3.5 - 4 year time frame, Mitsui imported 6,922,080 kgs of bio-sa from LCY Biosciences for the last 4 years..
https://www.importgenius.com/suppliers/lcy-biosciences-inc
Reminder; Bioamber Sarnia's secured creditor Mitsui = $4,416,203 CAD or roughly $3.1 million USD
I'd ask why did, and or does it make sense that Mitsui imported from LCY Biosciences 6,922.080 kgs @ 2.00 per/kg = $13,844,160 USD or @ 2.50 per/kg = $17,305,200 USD ?
Wish I knew when but I don't, however would refer to the following articles and quotes:
"KKR said that the Carlton shares acquired following the takeover would not pay dividends and would have no liquidity in the next five years."
- https://www.taipeitimes.com/News/biz/archives/2018/09/08/2003699991
"Hung is aiming to have LCY return to the capital market in five to seven years as a stronger and more profitable company."
- https://www.taipeitimes.com/News/biz/archives/2019/01/31/2003708947
If I had to guess sometime between July 2023 and/or after Jan 2024, considering above & the following;
- LCY/KKR 5 year mark statements, deal annoucement & closing dates
- Completion of LCY Electronics Materials Inc's IPA plant in Arizona, TSMC mentioned starting production in 2024.
On another note, here's a Feb 2017 quote from Christopher Ellen, BioAmber’s vice president of sales;
"According to Ellen, succinic acid can substitute for IPA, at a similar price and at a 30% lower level. Renewability is another advantage"
- https://cen.acs.org/articles/95/i7/BioAmber-crafts-succinic-acid-market.html
Considering Ellen's statement above, Anybody else thinking LCY used/using Bioamber's assets as collateral for a USD 700 million loan to build the Arizona Electronic-grade IPA plant?
Another quote from the 'cen.acs.org' article above;
"Roy McDowall, who runs strategy for BioAmber, says the infrastructure of the Chinese plant is “virtually identical” to that of the Sarnia facility. “It’s like we have the KFC recipe and we’re going into a Popeye’s and taking over,” he says."
If you think PWC screwing up a sealed bid process for what seems to be a pre-determined outcome is funny, I can only imagine you'd find my thoughts about the company name 'Vertubio' hilarious.
Verdezye + Portmanteau + Bioamber = LCY Biosciences & Nutrition (Verdezyne Inc's assets not included, Verdezyne (ABC), LLC took care of those)
Check out Vertubio's incoporation date for a roll on the floor bell aching chuckle.
/s
So weeks prior to the deadline & during the "sealed" bidding process, PWC mishandled sealed bidding info and pre-maturely published two companies' names, causing those two companies to pull their bids, which ultimately made way for Visolis/LCY's liquidation offer? Then LCY Biotechnology Holding Inc is formed, and receives a three-quarters of a billion (USD) dollar loan?
As collateral to LCY 's lender, I'm guessing $770 million sounds about right for the value of Bioamber's plant(s), patents, trademarks, NOLS, clean-energy/ green tax credits, shares.
https://www.lcyt.com.tw/tc/news-info.php?cid=3&nid=307&Page=3
LCY Biotechnology Holding Inc.
Rough translation = 7.As of the date of the fact, the fund loan and balance:$770,162,730
THAILAND: THE HUB OF BIO-PLASTICS, (Refer to Page 9)
Per the pie chart on Page 9:
The Grey slice of the chart (on Page 9) indicates PTTMCC received a THB 3.17 Billion investment (approx USD 95 Million) for a BSA (bio-succinic acid) plant w/ a 34,000 ton capacity. I believe Bioamber is the only BSA plant in the world with 34,000tpa capacity. PTTMCC ultimately purchased Myriant's IP & Louisiana which only had 13,600 tpa capacity for an undisclosed amount. Anybody have a clue as to why was Bioamber's plant seemingly referenced in this pie chart? And did Bioamber ever receive an investment totalling approx $USD 95 million from either Thailand and/or PTT MCC.
The Purple slice of the chart (on Page 9) indicates PTTMCC received a THB 3.24 Billion investment (approx USD 97 million) for a BDO plant w/ a 45,000 ton capacity. To my understanding no such bio-bdo plant w/ 45,000 tpa existed, However one was being planned per the March 14, 2014 link and summary below:
https://processdesign.mccormick.northwestern.edu/index.php/Design_S2
- "Bio-succinic acid can be easily used in the Davy process as a substitute for maleic acid to form the end product, BDO (Nexant.com). It is this process that Team S2Kool4Skool has chosen to develop for a new bio-butanediol plant, because the Davy method is mature and requires no new innovations, and because an appropriate feedstock of bio-succinic acid is now available. The plant will be located in East Carroll Parish, Louisiana. This county is also home to Myriant; located in Lake Providence, they are the largest domestic provider of bio-succinic acid. Furthermore, Lake Providence is conveniently located on the Mississippi River, which will allow for affordable transportation of our bio-based butanediol product. The intent of this project is to produce 45,000 metric tonnes of 99.5 wt% 1,4-butanediol per year in a new plant in Lake Providence, LA. - March 2014"
Keyword: "Also" meaning not Myriant.
Fast forward 5 years later and after PTTMCC acquired Myriant;
Thailand Board of Investment Points Out the High Potential for Thailand to Be
Bioplastics Hub - 15 January 2020
https://www.boi.go.th/upload/content/No.11_2563_EN_5e2133754e0d3.pdf
"PTT MCC Biochem, a joint venture between Thailand’s PTT Global Chemical PCL,
and Japan’s Mitsubishi Chemical Corporation (MCC), has also received BOI’s investment
incentives for its production facility in Rayong. The plant of a biochemical called bio-
butanediol (BIO BDO) made from raw materials including raw sugar and cassava."
Below is a quote from a (2011) article - LanzaTech and LCY to Target Bio-based Chemicals Market
"Mr Lee says LCY plans to investigate alternative bio-C2 to C5 feedstock as raw materials, replacing petroleum oil for LCY’s current portfolio of products such as TPE, PP, solvents, and methanol derivatives. LCY is also looking to further developments in bio green products including bio-plastics and bio-fuels."
Anybody else wondering if Bioamber's bio-succinic acid & bdo are being vertically integrated with lcy chemical's production of their performance plastics, elastomer solutions & solvent products?
if they are, wouldn't it be safe to assume LCY is not worried about global demand fluctuations of bio succinic acid, as they would be using what they produce?
On another note, I do feel for the 30 people LCY Biosciences laid-off per the Jan 26th article. If the 30 people are in Sarnia, hopefully Origin Materials would consider employing them after (coincidentally) announcing on Jan 27th their 1st plant is "mechanically complete".
To also note: It appears PTT did not give up on bio-succinic acid and/or bio-bdo considering PTTMCC biochem is active, producing & promoting Bio-PBS (as recent as the Pack Expo International 2022 held last month).
However, considering PTT/Myriant's bio-succinic acid plat in Louisiana sold recently, I'm just not sure where PTTMCC is sourcing or producing the bio-succinic acid used for their Bio-PBS.
So your point is Deloitte made sure the trading of XEBEQ shares were suspended on Nov 14 2022 prior to the bid submission deadline on Jan 6 2023?
Or is your point Deloitte made sure the trading of XEBEQ shares were suspended on Nov 14 2022, 3 days after the LOI deadline on Nov 11 2022?
Is there anything comparable or relevant to PWC leaking & revealing the sealed bidders' names prior to the bid submission deadline, or allowing Bioamber's shares to trade for 13+ months after Visolis & LCY were declared the purchasers?
"PTT Global only thought about buying the assets" and expressed that "thought" via PWC's sealed bid process. PWC broke the sealed bid's protocol by revealing the bidders prior to the deadline.
PTT's $USD 40-60 million bid = $CAD 53-80 million
Bioamber's Debt per PWC's creditor's list: $CAD 63,224,024 = $USD 46,861,947
Greenfield's bid of $CAD 15-30 million, if combined with $CAD 20 million from Bioamber's checking $USD 1.9 million & receiavbles $USD 14 million, would've at least satisfied the secured creditors.
Regardless PWC broke protocol, revealed two bidders prior to the bidding deadline resulting in LCY (KKR) & Visolis getting their bid in and I as other bioamber shareholders believe good things are coming & waiting.
For reference purposes only:
June 17, 2013 - June 17, 2013 - Myriant Corp., a global renewable chemicals company, has announced the successful start-up at its flagship bio-succinic acid plant located in Lake Providence, La.
August 21, 2018 - August 21, 2018 - PTT made following investments in Myriant: $60 million in 2014 and $ 6.15 million in 2017. Myriant restructured its operations beginning of 2017 from producing biosuccinic acid towards R&D. Myriant officialy changed its name to GC Innovation America on 1st August 2018.
Feb. 2, 2021 - Feb. 2, 2021 - Stepan Company reported that it has closed on the acquisition of a fermentation plant located in Lake Providence, Louisiana. Financial terms of the transaction were not disclosed. "Fermentation is a new platform technology for Stepan Company as we look to commercialize next generation surfactants. Bio-surfactants, produced via fermentation, are attractive due to their favorable biodegradability, low toxicity, and in some cases, unique antimicrobial properties," said F. Quinn Stepan Jr., Chairman and Chief Executive Officer of Stepan Company.